Early Detection Research Network

Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.

No abstract available.

Beltran H, Bismar TA, Dhir R, Erbersdobler A, MacDonald TY, Mosquera JM, Nanus DM, Nelson JB, Park K, Perner S, Robinson BD, Rubin MA, Tagawa ST


Neoplasia, 2013, 15 (1)